JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1987; 66:517-522
© 1987 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowdle, T. A.
Right arrow Articles by Schoene, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowdle, T. A.
Right arrow Articles by Schoene, R. B.

Butorphanol Improves CO2 Response and Ventilation after Fentanyl Anesthesia

T. Andrew Bowdle, MD PhD, Sharon L. Greichen, RN, MN, Robert L. Bjurstrom, MD, and Robert B. Schoene, MD

University of Washington, Seattle, Washington.

Abstract

We have determined that the mixed agonist-antagonist narcotic, butorphanol, improves CO, response and ventilation after fentanyl anesthesia. A tentative dosage range has been established. Twenty-two patients were anesthetized with isoflurane, nitrous oxide, and fentanyl, which was continuously infused throughout the study. Postoperatively three 1-mg doses of butorphanol were administered IV. Blood pressure, heart rate, plasma epinephrine and norepinephrine concentrations, and pain intensity were essentially unchanged after butorphanol. Most of the improvement in breathing occurred after the first 1-mg dose. Mean respiratory rate increased from 7.8 ± 5.0 to 11.0 ± 4.8 min (P <= 0.005), tidal volume increased from 469 ± 302 to 844 ± 390 ml (P <= 0.005), minute ventilation increased from 4.32 ± 2.97 to 8.51 ± 3.14 L/min (P <= 0.005), and the slope of the ventilatory response to CO2 increased from 0.36 ± 0.37 to 0.90 ± 0.80 L·min 1·mm Hg 1(P <= 0.05). Resting PaCO2 decreased from a baseline of 57.8 <= 11.1 to 51.7 ± 5.12 mm Hg (P <= 0.05) after the third dose.

Key Words: ANALGESICS—fentanyl, butorphanol • ANTAGONISTS, narcotic—butorphanol • VENTILATION—CO2 response curves




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. R. Garner, T. F. Burke, C. D. Lawhorn, J. M. Stoner, and W. D. Wessinger
Butorphanol-Mediated Antinociception in Mice: Partial Agonist Effects and Mu Receptor Involvement,
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1253 - 1261.
[Abstract] [Full Text]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1987 by the International Anesthesia Research Society.